Evaluating Dynamic Arterial Elastance in Septic Shock Patients.
ConditionSeptic Shock
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-120
SponsorFundación Santa Fe de Bogota
About this trial
Assess the effectiveness and safety of using dynamic arterial elastance as a tool for weaning vasopressor support in patients with septic shock, compared to a control group
Eligibility criteria
Qualifiers
≥ 18 years of age.
Admission to the ICU.
Septic shock defined according to the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).
Hypotension requiring vasopressor support to maintain a MAP ≥ 65 mmHg.
Disqualifiers
Pregnant individuals.
Hemodynamic instability due to cardiac arrhythmias.
Hepatic cirrhosis.
Kidney or liver transplant.
Trial design
Treatments tested in this trial
- EaDyn Weaning Arm:
- PAM Weaning Arm:
Treatment groups
114 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov